Auctus Advisors
Stephane Foucaud
Hartshead Resources NL (ASX: HHR): Delivering a re-rating farm-in transaction
• Hartshead is farming out 60% WI of its UK assets to RockRose Energy for a combination of cash (US$34.4 mm/A$52.9 mm) and net free carry (US$61.8 mm/A$95 mm) for Phase I. A further US$5.9 mm cash payment is contingent on the NSTA approval of the FDP for the Phase II Lovelace or Hodgkin. RockRose currently produces ~27 mboe/d in the UK North Sea.
• The fact that a proportion of the proceeds is in cash (US$34.4 mm/A$52.9 mm) allows Hartshead to directly fund a larger share of capex and capture the generous tax benefits on UK capex. ~90% of UK capex can be deducted from payable taxes. If this amount had been provided as net carry, RockRose would have kept the associated tax benefit (~US$31 mm/A$48 mm).
• Hartshead is also raising A$20 mm of new equity priced at A$0.04 per share to boost the balance sheet.
• The total cash and net carry that Harshead is receiving amounts to ~US$96 mm/A$148 mm or A$0.053/sh. This is well above the price of the equity raise. Adding the tax benefits would lead to overall net proceeds for the Phase I farm-out of ~US$128 mm/A$196 mm of A$0.07/sh.
• The read through value of the retained 40% in Hartshead’s UK assets is US$64 mm/A$99 mm (A$0.035-0.047/sh).
• Overall, this transaction provides an industry valuation on Harsthead’s equity of A$0.088-0.117/sh, which is well above the current share price. it also provides Hartshead with enough funding to reach first gas.
• As we incorporate the impact of the farm out and the equity issued in the placing, we have changed our target price to A$0.17 per share.
Cash flow waterfall and capex programme
Hartshead will receive US$7.9 mm/A$12.2 mm on completion of the farm-out. From FID, expected in 3Q23, RockRose will carry Hartshead’s net development cost for up to US$61.8 mm/A$95 mm. At FID, RockRose will also pay Harthead A$9.8 mm with a further cash payment of A$31.7 mm on FDP approval later in 2023. Gross capex to first gas is ~£200 mm/US$250 mm (£80 mm/US$100 mm) net to Hartshead which can be funded by the proceeds from the divestment and the equity raise. A further £150 mm/US$185 mm (£60 mm/US$75 mm net to Hartshead) is required post first gas to fully develop the field. This will be funded by a combination of debt and cashflow.
Valuation
The NPV of the farm-out is very close to what we were assuming. As we now increase the chance of Phase I development to 100% but incorporate the impact of the equity raise, our new Core NAV is A$0.13/sh with a ReNAV including Phase II of A$0.17 per share.
05/04/2023
Source
- Forums
- ASX - By Stock
- HHR
- Updated Auctus Advisors Report
Updated Auctus Advisors Report
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HHR (ASX) to my watchlist
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.85M |
Open | High | Low | Value | Volume |
0.6¢ | 0.7¢ | 0.6¢ | $7.949K | 1.210M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
35 | 16453773 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 4134766 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
34 | 16203773 | 0.006 |
21 | 10370180 | 0.005 |
9 | 4820833 | 0.004 |
2 | 3600000 | 0.003 |
3 | 4000000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 4000000 | 3 |
0.008 | 2857918 | 9 |
0.009 | 2918444 | 7 |
0.010 | 1826000 | 5 |
0.011 | 1020777 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
HHR (ASX) Chart |